Biohit OyjLTS:0DRP +3.79%78 Days Inventory is 64.60 as of Dec. 2025, which is 21% below its 10-year median of 81.91. GuruFocus rates LTS:0DRP with a GF Score™ of 78/100 and a GF Value™ of €2.79 (Fairly Valued). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Biohit Oyj ranks better than 90.71% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Biohit Oyj's Average Total Inventories for the
six
months ended in Dec. 2025 was €0.85 Mil. Biohit Oyj's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €2.40 Mil.
Hence, Biohit Oyj's Days Inventory for the
six
months ended in Dec. 2025 was 64.60.
The historical rank and industry rank for Biohit Oyj's Days Inventory or its related term are showing as below:
LTS:0DRP'
s Days Inventory Range Over the Past 10 Years
Min: 66.95 Med: 81.91 Max: 109.15
Current: 67.74
During the past 13 years, Biohit Oyj's highest Days Inventory was 109.15. The lowest was 66.95. And the median was 81.91.
LTS:0DRP's Days Inventory is ranked better than 90.71% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs LTS:0DRP: 67.74
Biohit Oyj's Days Inventory
declined
from Dec. 2024 (88.31) to Dec. 2025 (64.60).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Biohit Oyj's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biohit Oyj's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.10.
Biohit Oyj (LTS:0DRP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Biohit Oyj's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biohit Oyj's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Biohit Oyj Days Inventory Related Terms
Biohit Oyj Days Inventory Historical Data
* Premium members only.
The historical data trend for Biohit Oyj's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0DRP vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Biohit Oyj's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biohit Oyj Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biohit Oyj's Days Inventory distribution charts can be found below:
* The bar in red indicates where Biohit Oyj's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biohit Oyj (LTS:0DRP) has a Days Inventory of 64.60 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biohit Oyj and its competitors. This is 21% below median its historical median of 81.91. Over the past decade, Biohit Oyj's Days Inventory has ranged from 66.95 to 109.15. According to the industry distribution chart, Biohit Oyj ranks #73 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 9.3%.
Is Biohit Oyj's Days Inventory too high?
Biohit Oyj's current Days Inventory of 64.60 is 21% below median its 10-year median of 81.91. Over the past 10 years, this metric has ranged from a low of 66.95 to a high of 109.15. The Medical Devices & Instruments industry median Days Inventory is 179.60. Biohit Oyj's value of 64.60 is 64% below this industry median. Based on the distribution chart, Biohit Oyj ranks #73 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Biohit Oyj has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biohit Oyj's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Biohit Oyj ranks #73 out of 786 companies for Days Inventory. This places Biohit Oyj in the top 9% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Biohit Oyj's value of 64.60 is 64% below this benchmark. Historically, Biohit Oyj's own Days Inventory has ranged from 66.95 to 109.15 over the past decade. While the company's 10-year median is 81.91 vs. the industry median of 179.60, Biohit Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biohit Oyj's current Days Inventory of 64.60 is 64% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biohit Oyj and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biohit Oyj's current Days Inventory is 64.60, which is 21% below median its own 10-year median of 81.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biohit Oyj stock overvalued right now?
Based on GuruFocus' analysis, Biohit Oyj (LTS:0DRP) is currently considered Fairly Valued. The stock's GF Value™ is €2.79, compared to a current price of €2.74 — trading 1.8% below its estimated fair value. The current Days Inventory is 64.60, which is 21% below median its 10-year median of 81.91 and 64% below the Medical Devices & Instruments industry median of 179.60. Biohit Oyj's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Biohit Oyj (LTS:0DRP), the current Days Inventory is 64.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biohit Oyj (LTS:0DRP) Overvalued in 2026?
Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued.
The current stock price of €2.74 is trading 1.8% below its estimated GF Value™ of €2.79.
GuruFocus considers Biohit Oyj to be Fairly Valued.
Key valuation signals for LTS:0DRP:
Days Inventory: 64.60 (21% below median its 10-year median of 81.91)
GF Value™: €2.79 vs. price of €2.74 (1.8% below fair value)
Industry Position: 64% below the Medical Devices & Instruments median (#73 of 786)
No single metric tells the full story. See the LTS:0DRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
78GF Score
Get the complete analysis for LTS:0DRP
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DRP has been successfully added to your 
